The government first announced a ban on parallel exporting 23 types medication including Alogliptin in October

The Department of Health and Social Care (DHSC) today announced the removal of Alogliptin from the list of medicines which cannot be parallel-exported from the UK.

The restrictions are removed with immediate effect, according to the government department.

The government first announced a ban on parallel export of 23 types of medical devices and drugs, including oral anti-diabetic drug Alogliptin, in October and later added 11 more to the list.

The list currently includes Adrenaline auto-injectors, Hepatitis B vaccine, Hepatitis B (rDNA) suspension injection, Misoprostol, Pneumococcal Polysaccharide vaccine, and Hepatitis A and B vaccine.

Any manufacturer or wholesaler found guilty of parallel-exporting one or more of the listed medicines could face immediate licence suspension.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY